We provide evidence that MYCN targeting miRNAs are preferentially downregulated in MYCN-driven neuroblastoma tumors, suggesting that MYCN negatively controls the expression of these miRNAs, and as such safeguards its own expression. Here, MYCN is linked to neuroblastoma.